Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare - Concepedia

Concepedia

Publication | Open Access

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

DOI Full Paper Access

73

Citations

22

References

2021

Year

Siew Eng Choon, Mark Lebwohl, Slaheddine Marrakchi, A. David Burden, Tsen‐Fang Tsai, Akimichi Morita, Alexander A. Navarini, Min Zheng, Jinhua Xu, H. Turki,

Abstract

ClinicalTrials.gov identifier: NCT03782792; Pre-results.

References

	Year	Citations

Page 1